Cipher Pharmaceuticals Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
Cipher Pharmaceuticals Stock Forecast and Price Target
Given the average yearlong price target of C$8.00 provided by prominent analysts over the past few months, there is a potential downside of approximately -7.83% from the last closing price in May, 2024 for Cipher Pharmaceuticals's stock if it is reached. This estimation is based on a high estimate of C$9.25 and a low estimate of C$5.60. Even if you are not interested in CPH stock, it is still crucial to be aware of its competitors.
-7.83% Downside
Cipher Pharmaceuticals Fair Value Forecast for 2023 - 2025 - 2030
In the last zero years, Cipher Pharmaceuticals's Price has grown from C$0.00 to C$0.00 – a 100.00% increase. Next year, analysts are expecting Fair Value to reach C$6.15 – an increase of 100.00%. Over the next seven years, the forecast is for Fair Value to grow by 100.00%.
Cipher Pharmaceuticals Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Cipher Pharmaceuticals's Revenue has decreased from C$21.61M to C$20.68M – a 4.30% drop. Next year, analysts are expecting Revenue to reach C$21.42M – an increase of 3.56%. Over the next eight years, the forecast is for Revenue to grow by 3.67%.
.jpg)
Cipher Pharmaceuticals EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Cipher Pharmaceuticals has seen a decline in its EBITDA, from C$13.22M to C$11.95M – a 9.61% decrease. In the next year, analysts believe that EBITDA will reach C$17.44M – an increase of 45.94%. For the next seven years, the forecast is for EBITDA to grow by 231.46%.
Cipher Pharmaceuticals EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Cipher Pharmaceuticals's EBIT has decreased by 9.13%, from C$12.16M to C$11.05M. In the next year, analysts believe that EBIT will reach C$12.14M – an increase of 9.83%. For the next eight years, experts predict that Cipher Pharmaceuticals's EBIT will grow at a rate of 10.49%.
Cipher Pharmaceuticals EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last zero years, Cipher Pharmaceuticals's EPS has grown from C$0.00 to C$0.00 – a 100.00% increase. Next year, analysts are expecting EPS to reach C$0.41 – an increase of 100.00%. Over the next seven years, the forecast is for EPS to grow by 100.00%.
Site Navigation
.jpg)